Zhejiang Tianyu Pharmaceutical Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Zhejiang Tianyu Pharmaceutical Co., Ltd. was established in 2003 and is a joint-stock pharmaceutical listed enterprise specializing in the research and development, manufacturing, and sales of formulations, raw materials, and pharmaceutical intermediates. It now has eight wholly-owned subsidiaries, covering an area of over 700 acres. It is a national high-tech enterprise and a national intellectual property demonstration enterprise. The company's main products cover pharmaceutical intermediates and raw materials such as blood pressure lowering, hypoglycemic, antithrombotic, asthma, and antiviral drugs. It is one of the world's largest manufacturers of raw materials and intermediates for sartan drugs. More than 50% of its products serve well-known international and domestic pharmaceutical companies such as TEVA, POLPHARM, NOVARTIS SANDOZ, and is in a leading position among similar manufacturers in China. |
| Headquarter | Taizhou |
| Establish Date | 2/14/2003 |
| Listed Code | 300702.SZ |
| Listed Date | 9/19/2017 |
| Chairman | Tu Yongjun. |
| CEO | Tu Yongjun. |
| Website | www.tianyupharm.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
